Bellerophon Therapeutics, Inc. BLPH
Set alert
0.01 +0.01 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 146.79K
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.45
- Beta
- 0.60
- Short ratio
- 0.39
- Inst. own
- 44.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 17, 2024
- 50-d avg
- 4.34
- 200-d avg
- 3.45
- 1y target
- 2.00
YTD chart
Events in this range
- Jul 1, 2024Earnings: —; estimate 0; surprise —%
- Sep 30, 2024Earnings: —; estimate 0; surprise —%
- Dec 17, 2024Earnings: —; estimate 0; surprise —%
Signals (56)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 18, 2024 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| RSI: Oversold | Dec 9, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 3, 2024 | 1 year ago |
| SMA: Bearish | Nov 29, 2024 | 1 year ago |
| SMA: Bullish | Nov 21, 2024 | 1 year ago |
| RSI: Overbought | Nov 5, 2024 | 1 year ago |
| SMA: Bullish | Oct 11, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 22, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 6, 2024 | 2 years ago |
| RSI: Oversold | Aug 6, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 23, 2024 | 2 years ago |
| SMA: Bearish | Jun 20, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 20, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 7, 2024 | 2 years ago |
| RSI: Overbought | Jun 7, 2024 | 2 years ago |
| SMA: Bullish | Jun 6, 2024 | 2 years ago |
| SMA: Bearish | Jun 3, 2024 | 2 years ago |
| MACD: Sell Signal | May 24, 2024 | 2 years ago |
| MACD: Buy Signal | May 20, 2024 | 2 years ago |
Newest 20 of 56.
Analyst view
Consensus: buy
Buy
Price target (mean) 2.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 4
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40 | -0.42 – -0.39 | -0.43 | +7.0% | 0 | 0.0% | 2 |
| Next quarter | -0.42 | -0.44 – -0.41 | -0.53 | +20.8% | 0 | 0.0% | 2 |
| Current year | -1.05 | -1.11 – -1.00 | -2.08 | +49.5% | 5.64M | 0.0% | 2 |
| Next year | -1.67 | -1.82 – -1.53 | -1.05 | -59.0% | 1.33M | -76.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 6, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 6, 2023 | Laidlaw & Co. | Downgrade | Buy | Hold |
| May 9, 2023 | Laidlaw & Co. | Initiated | — | Buy |
| Apr 4, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |
| Nov 25, 2020 | Maxim Group | Initiated | — | Buy |
| Nov 25, 2020 | H.C. Wainwright | Initiated | — | Buy |
| Nov 25, 2020 | Leerink Swann | Initiated | — | Outperform |
| Nov 25, 2020 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Nov 25, 2020 | Cowen & Co. | Initiated | — | — |